Release the potential of doxazosin:
An exclusive interview with Claus Roehrborn, MD, on BPH management.
Claus Roehrborn, MD, is Professor and Chairman of the Department of Urology at
the University of Texas Southwestern, and has been involved in the American
Urological Association BPH guideline efforts from their inception.
Hear Claus Roehrborn's insights on:
The current state of care in BPH
Treatment optimization
The latest medications
To request your DVD, fill out the information below
*denotes required fields
First Name*
Last Name*
Address*
Apt. Number
City*
State*
Zip Code*
Phone Number
Email Address
Year of Birth*
License Number:
Practice Specialty:
Pfizer respects your right to have your personal and health information kept
private. We may use this information to send you materials on our products and
services that may be of interest to you. Pfizer and the companies that work
with us to provide these materials will not share your information with any
other third parties or outside mailing lists.
Along with the material you asked us to send, Pfizer may want to contact you
from time to time about special offers and updates on Caverject Impulse and
related health issues. Check here if you would like this information.
Check here if you also agree that Pfizer and companies working with Pfizer may
use your information to help develop Pfizer products, services, and other
programs, provide you with materials you may find useful, and contact you about
health-related topics.
If you do not check either box, we will fill just this one-time request.
Do you currently use Caverject Impulse?
Yes
No
Would you like to receive Pfizer brochures on ED and a specific health
condition? Check all that apply.
Information on
diabetes and ED
Information on heart
health concerns and ED
Information on nerve
injury and ED
Information on
depression and ED
Information on ED
and benign prostatic hyperplasia, known as BPH or enlarged prostate
Would you like the FREE Pfizer for Men magazine? Its full of valuable healthy
news and other tips for healthy living? Yes
No
Important Safety Information
CARDURA XL is contraindicated in patients with a known
sensitivity to other quinazolines (eg, prazosin, terazosin), doxazosin, or any
of the inert ingredients. Postural hypotension with or without symptoms (eg,
dizziness) may develop within a few hours following administration of CARDURA
XL. However, infrequently, symptomatic postural hypotension has also been
reported later than a few hours after dosing.
Caution should be used when administering CARDURA XL to patients with
preexisting severe gastrointestinal tract narrowing, chronic constipation, or
evidence of hepatic dysfunction.
The most commonly reported adverse events were: headache, dizziness,
respiratory tract infection, asthenia, and back pain.
